Treatment Intensification in Type 2 Diabetes

Serge Jabbour, MD


June 17, 2022

Currently, many clinicians intensify treatment for type 2 diabetes by a stepwise addition of medications to initial monotherapy as glycemic control weakens. However, recent studies support the strategy of starting with combination treatment for faster glycemic control. Despite evidence of benefit, treatment intensification is often delayed due to clinician hesitation.

In this ReCAP, Dr Serge Jabbour, from Thomas Jefferson University, discusses guidelines for prompt treatment intensification, citing specific recommendations for patients with underlying heart or kidney disease.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.